Patent details

EP3666283 Title: FACTOR VIII POLYPEPTIDE FORMULATIONS

Basic Information

Publication number:
EP3666283
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP192129005
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FACTOR VIII POLYPEPTIDE FORMULATIONS
French Title of Invention:
FORMULATIONS DE POLYPEPTIDE DE FACTEUR VIII
German Title of Invention:
FAKTOR-VIII-POLYPEPTIDFORMULIERUNGEN
SPC Number:

Dates

Filing date:
14/03/2014
Grant date:
08/06/2022
EP Publication Date:
17/06/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/06/2022
EP B1 Publication Date:
08/06/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/03/2023
Expiration date:
14/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/06/2022
 
 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham MA 02451, United States (US)

Inventor

1

Name:
MALONEY, Kevin
Address:
United States (US)

2

Name:
GAGE, Daniel
Address:
United States (US)

3

Name:
ABDUL-FATTAH, Ahmad
Address:
United States (US)

Priority

1

Priority Number:
201361800293 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

2

Priority Number:
201361817085 P
Priority Date:
29/04/2013
Priority Country:
United States (US)

3

Priority Number:
201361829884 P
Priority Date:
31/05/2013
Priority Country:
United States (US)

4

Priority Number:
201361839477 P
Priority Date:
26/06/2013
Priority Country:
United States (US)

5

Priority Number:
201361863860 P
Priority Date:
08/08/2013
Priority Country:
United States (US)

6

Priority Number:
201361876927 P
Priority Date:
12/09/2013
Priority Country:
United States (US)

7

Priority Number:
201361879955 P
Priority Date:
19/09/2013
Priority Country:
United States (US)

8

Priority Number:
201361897742 P
Priority Date:
30/10/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/37; A61P 7/00; A61P 7/04; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:
202223
Publication date:
08/06/2022
Description:
Grant (B1)

2

Issue number:
202229
Publication date:
20/07/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages